Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Histologic Type × ruxolitinib × Clear all

Sponsor

Conditions

Primary Myelofibrosis 15 Myeloproliferative Disorders 13 Polycythemia Vera 8 Breast Neoplasms 6 Leukemia, Myeloid, Acute 5 Leukemia 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Hematologic Diseases 4 Myelodysplastic Syndromes 3 Bone Marrow Diseases 3 Thrombocytosis 2 Thrombocythemia, Essential 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Graft vs Host Disease 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia-Lymphoma, Adult T-Cell 1

Interventions

ponatinib 4 Rituximab 3 Gemcitabine 3 130-nm albumin-bound paclitaxel 3 pralsetinib 2 pembrolizumab 2 napabucasin 2 Vincristine 2 Prednisone 2 Irinotecan 2 Imatinib Mesylate 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Brentuximab Vedotin 2 tetulomab tetraxetan lu-177 1 pamiparib 1 nirogacestat 1 nilotinib 1 ibritumomab tiuxetan 1 bosutinib 1 blinatumomab 1 Vorinostat 1 Temozolomide 1 Radiation 1 Pemetrexed 1 Papanicolaou Test 1 Paclitaxel 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡